Caxton Associates (New York)’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
Caxton Associates (New York)'s JNJ Position: Q3 2024 in Review
Caxton Associates (New York) sold out of Johnson & Johnson (JNJ) in Q3 2024, closing a stake of 18,341 shares — an estimated $2.68M sold.
Caxton Associates (New York) first reported a position in JNJ in Q3 2017 and held it in 19 quarters. The position peaked at $7.3M in Q2 2021. 3,881 funds tracked by Wall St. Rank hold JNJ as of Q3 2024.
- Caxton Associates (New York) reported no remaining Johnson & Johnson position as of Q3 2024 after selling out during the quarter.
- Caxton Associates (New York) sold 18,341 Johnson & Johnson shares in Q3 2024, an estimated $2.68M.
- Caxton Associates (New York) first reported a position in Johnson & Johnson in Q3 2017 and held it in 19 quarters.
- Caxton Associates (New York)'s Johnson & Johnson position peaked at $7.3M in Q2 2021.
- 3,881 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2024.
Based on Caxton Associates (New York)'s 13F filing for Q3 2024, filed 14 Nov 2024.